Successful treatment with paclitaxel of advanced AIDS-associated Kaposi's sarcoma

Internal Medicine

Volumn 41, Issue 12, 2002, Pages 1209-1212

  Kobayashi, Masayuki ^a   Takaori Kondo, Akifumi ^a   Shindo, Keisuke ^a   Mizutani, Chisato ^a   Ishikawa, Takayuki ^a   Uchiyama, Takashi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

HAART; HIV 1; Immune restoration

Indexed keywords

AMPHOTERICIN; ANTIRETROVIRUS AGENT; AZATHIOPRINE; BLEOMYCIN; CD4 ANTIGEN; CEFOZOPRAN; DOXORUBICIN; FAMCICLOVIR; GANCICLOVIR; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; LAMIVUDINE; OXYGEN; PACLITAXEL; VANCOMYCIN; VINCRISTINE; VIRUS RNA;

ADULT; ADVANCED CANCER; AIDS RELATED COMPLEX; ARTICLE; ASSISTED VENTILATION; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER RECURRENCE; CANCER REGRESSION; CASE REPORT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFICACY; DYSPNEA; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; JAPAN; KAPOSI SARCOMA; LUNG PARENCHYMA; LUNG TOXICITY; LYMPHOCYTE COUNT; MALE; PLEURA EFFUSION; T LYMPHOCYTE; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

EID: 0036970573     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.41.1209     Document Type: Article

References (16)

1. Antman K, Chang Y. Kaposi's Sarcoma. N Engl J Med 342: 1027-1038, 2000.
2. Gill PS, Akil B, Colletti P, et al. Pulmonary Kaposi's sarcoma: clinical findings and results of therapy. Am J Med 187: 57-61, 1989.
3. Harrison M, Tomlinson D, Stewart S. Liposomal-entrapped doxorubicin: an active agent in AIDS-related Kaposi's sarcoma. J Clin Oncol 13: 914-920, 1995.
4. Krown SE, Real FX, Cunningham-Rundles S, et al. Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposi's sarcoma. N Engl J Med 308: 1071-1076, 1983.
5. Welles L, Saville MW, Lietzau J, et al. Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma. J Clin Oncol 16: 1112-1121, 1998.
6. Gill PS, Tulpule A, Espina BM, et al. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma. J Clin Oncol 17: 1876-1883,1999.
7. Saville MW, Liezau J, Pluda JM, et al. Treatment of HIV-associated Kaposi's sarcoma with paclitaxel. LANCET 346: 26-28, 1995.
8. Cooney EL. Clinical indicators of immune restoration following highly active antiretrovial therapy. Clin Infect Dis 34: 224-233, 2002.
9. Gill PS, Wernz J, Scadden DT, et al. Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma. J Clin Oncol 14: 2353-2364, 1996.
10. Komanduri KV, Viswanathan MN, Wieder ED. Restoration of cytomegalovirus-specific CD4+ T lymphocyte responses after ganciclovir and highly active antiretrovial therapy in individuals infected with HIV-1. Nat Med 4: 953-956, 1998.
11. Tulpule A, Groopman J, Saville MW, et al. Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma. Cancer 95: 147-154, 2002.
12. Hermans P. Kaposi's sarcoma in HIV-infected patients: treatment options. HIV Med 1: 137-142, 2000.
13. Noel JC, Hermans P, Andre J, et al. Herpes virus-like DNA sequences and Kaposi's sarcoma: relationship with epidemiologic forms, clinical spectrum and histological features. Cancer 77: 2132-2136, 1996.
14. Hermans P. Opportunistic AIDS-associated malignancies in HIV-infected patients. Biomed Pharmacother 54: 32-40, 2000.
15. Kirk O, Lundgren JD, Pedersen C, Nielson H, Gerstoft J. Can chemoprophylaxis against opportunistic infections be continued after an increase in CD4 cells induced by highly active antiretrovial therapy? AIDS 13: 1647-1151, 1999.
16. EL Sadr WM, Burman WJ, Grant LB, et al. Discontinuation of prophylaxis against Mycobacterium avium complex disease in HIV-infected patients who have a response to antiretroviral therapy. Terry Beirn Community Programs for Clinical Research on AIDS. N Engl J Med 342: 1085-1092, 2000.